|
- Rheumatology | Oxford Academic
Authors interested in publishing in Rheumatology may be able to publish their paper Open Access using funds available through their institution’s agreement with OUP Find out if your institution is participating
- Issues | Rheumatology - Oxford Academic
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs
- About | Rheumatology - Oxford Academic
Rheumatology strives to support global research and discovery by publishing the highest quality scientific papers covering the full breadth of rheumatology, from hypothesis-generating basic results to translational and clinical research, as well as adult, adolescent, and paediatric conditions
- General Instructions | Rheumatology - Oxford Academic
Providing high-quality publishing for over 70 years, Rheumatology is an international, peer-reviewed journal covering the full breadth of rheumatology, from hypothesis-generating basic results to clinical research
- Guidelines | Rheumatology - Oxford Academic
All BSR guidelines are published in Rheumatology under an open access license or made free to access We also publish guidelines from other organisations Browse the latest guideline papers below
- Executive Summary: The 2025 British Society for Rheumatology guideline . . .
A suggested audit tool is available via the BSR website and in Supplementary Data S6, available at Rheumatology online The GWG encourages engagement with the BSR New Early Inflammatory Arthritis Audit
- British Society for Rheumatology guideline for the management of foot . . .
The guideline was developed in line with the British Society for Rheumatology Guidelines Protocol (version 5 4, November 2023) A lay summary of this guideline can be found in Supplementary File S1, available at Rheumatology online Background
- 2025 British Society for Rheumatology guideline for the treatment of . . .
This guideline is for health professionals in the UK who directly care for adults with axSpA (including but not limited to rheumatologists, rheumatology specialist nurses, allied health professionals, rheumatology specialty trainees, pharmacists), people living with axSpA and other stakeholders
|
|
|